Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

Phonon Lasing from Optical Frequency Comb Illumination of Trapped Ions.

Ip M, Ransford A, Jayich AM, Long X, Roman C, Campbell WC.

Phys Rev Lett. 2018 Jul 27;121(4):043201. doi: 10.1103/PhysRevLett.121.043201.

2.

Quantity of Intraretinal Hyperreflective Foci in Patients With Intermediate Age-Related Macular Degeneration Correlates With 1-Year Progression.

Nassisi M, Fan W, Shi Y, Lei J, Borrelli E, Ip M, Sadda SR.

Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3431-3439. doi: 10.1167/iovs.18-24143.

PMID:
30025092
3.

Ultra-Wide-Field Fluorescein Angiography-Guided Normalization of Ischemic Index Calculation in Eyes With Retinal Vein Occlusion.

Wang K, Ghasemi Falavarjani K, Nittala MG, Sagong M, Wykoff CC, van Hemert J, Ip M, Sadda SR.

Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3278-3285. doi: 10.1167/iovs.18-23796.

PMID:
29971447
4.

Scotopic Microperimetric Assessment of Rod Function in Stargardt Disease (SMART) Study: Design and Baseline Characteristics (Report No. 1).

Strauss RW, Kong X, Bittencourt MG, Ho A, Jha A, Schönbach EM, Ahmed MI, Muñoz B, Ervin AM, Michaelides M, Birch DG, Sahel JA, Sunness JS, Zrenner E, Bagheri S, Ip M, Sadda S, West S, Scholl HPN; for the SMART Study Group.

Ophthalmic Res. 2018 Jun 25:1-8. doi: 10.1159/000488711. [Epub ahead of print]

PMID:
29940588
5.

LONG-TERM PHYSICAL STABILITY, STERILITY, AND ANTI-VEGF BIOACTIVITY OF REPACKAGED BEVACIZUMAB IN 2-ML GLASS VIALS.

Peterson JS, Rockwell K Jr, Scott IU, Ip MS, VanVeldhuisen PC, Blodi BA; SCORE2 Investigator Group.

Retina. 2018 May 9. doi: 10.1097/IAE.0000000000002212. [Epub ahead of print]

PMID:
29746405
6.

Vascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoural high endothelial venules.

He B, Jabouille A, Steri V, Johansson-Percival A, Michael IP, Kotamraju VR, Junckerstorff R, Nowak AK, Hamzah J, Lee G, Bergers G, Ganss R.

J Pathol. 2018 Jun;245(2):209-221. doi: 10.1002/path.5080. Epub 2018 Apr 20.

PMID:
29603739
7.

Comparison of Monthly vs Treat-and-Extend Regimens for Individuals With Macular Edema Who Respond Well to Anti-Vascular Endothelial Growth Factor Medications: Secondary Outcomes From the SCORE2 Randomized Clinical Trial.

Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, Altaweel M, Berinstein DM; SCORE2 Investigator Group.

JAMA Ophthalmol. 2018 Apr 1;136(4):337-345. doi: 10.1001/jamaophthalmol.2017.6843.

PMID:
29476687
8.

Subfoveal choroidal thickness predicts macular atrophy in age-related macular degeneration: results from the TREX-AMD trial.

Fan W, Abdelfattah NS, Uji A, Lei J, Ip M, Sadda SR, Wykoff CC; TREX-AMD Study Group.

Graefes Arch Clin Exp Ophthalmol. 2018 Mar;256(3):511-518. doi: 10.1007/s00417-017-3888-2. Epub 2018 Jan 27.

PMID:
29374796
9.

Propranolol for Proliferative Diabetic Retinopathy.

Hendrick AM, Lavine JA, Domalpally A, Kulkarni AD, Ip MS.

Ophthalmic Surg Lasers Imaging Retina. 2018 Jan 1;49(1):35-40. doi: 10.3928/23258160-20171215-05.

PMID:
29304264
10.

Retinal Vein Occlusion Review.

Ip M, Hendrick A.

Asia Pac J Ophthalmol (Phila). 2018 Jan-Feb;7(1):40-45. doi: 10.22608/APO.2017442. Epub 2017 Dec 27. Review.

11.

SCORE2 Report 5: Vision-Related Function in Patients With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion.

Scott IU, Figueroa MJ, Oden NL, Ip MS, Blodi BA, VanVeldhuisen PC; SCORE2 Investigator Group.

Am J Ophthalmol. 2017 Dec;184:147-156. doi: 10.1016/j.ajo.2017.10.008. Epub 2017 Oct 23.

PMID:
29074161
12.

Angiopoietin-1 deficiency increases tumor metastasis in mice.

Michael IP, Orebrand M, Lima M, Pereira B, Volpert O, Quaggin SE, Jeansson M.

BMC Cancer. 2017 Aug 11;17(1):539. doi: 10.1186/s12885-017-3531-y.

13.

Distribution of Nonperfusion Area on Ultra-widefield Fluorescein Angiography in Eyes With Diabetic Macular Edema: DAVE Study.

Fan W, Wang K, Ghasemi Falavarjani K, Sagong M, Uji A, Ip M, Wykoff CC, Brown DM, van Hemert J, Sadda SR.

Am J Ophthalmol. 2017 Aug;180:110-116. doi: 10.1016/j.ajo.2017.05.024. Epub 2017 Jun 1.

PMID:
28579062
14.

Measurement and Reproducibility of Preserved Ellipsoid Zone Area and Preserved Retinal Pigment Epithelium Area in Eyes With Choroideremia.

Hariri AH, Velaga SB, Girach A, Ip MS, Le PV, Lam BL, Fischer MD, Sankila EM, Pennesi ME, Holz FG, MacLaren RE, Birch DG, Hoyng CB, MacDonald IM, Black GC, Tsang SH, Bressler NM, Larsen M, Gorin MB, Webster AR, Sadda SR; Natural History of the Progression of Choroideremia (NIGHT) Study Group.

Am J Ophthalmol. 2017 Jul;179:110-117. doi: 10.1016/j.ajo.2017.05.002. Epub 2017 May 10.

PMID:
28499705
15.

Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion: The SCORE2 Randomized Clinical Trial.

Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, Awh CC, Kunimoto DY, Marcus DM, Wroblewski JJ, King J; SCORE2 Investigator Group.

JAMA. 2017 May 23;317(20):2072-2087. doi: 10.1001/jama.2017.4568.

16.

Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4.

Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, King J, Antoszyk AN, Peters MA, Tolentino M; SCORE2 Investigator Group.

JAMA Ophthalmol. 2017 Jun 1;135(6):639-649. doi: 10.1001/jamaophthalmol.2017.1141.

17.

Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation.

Allen E, Jabouille A, Rivera LB, Lodewijckx I, Missiaen R, Steri V, Feyen K, Tawney J, Hanahan D, Michael IP, Bergers G.

Sci Transl Med. 2017 Apr 12;9(385). pii: eaak9679. doi: 10.1126/scitranslmed.aak9679.

18.

The Clinical Importance of Changes in Diabetic Retinopathy Severity Score.

Ip MS, Zhang J, Ehrlich JS.

Ophthalmology. 2017 May;124(5):596-603. doi: 10.1016/j.ophtha.2017.01.003. Epub 2017 Mar 8.

19.

QUANTIFICATION OF INTRARETINAL HARD EXUDATES IN EYES WITH DIABETIC RETINOPATHY BY OPTICAL COHERENCE TOMOGRAPHY.

Srinivas S, Nittala MG, Hariri A, Pfau M, Gasperini J, Ip M, Sadda SR.

Retina. 2018 Feb;38(2):231-236. doi: 10.1097/IAE.0000000000001545.

PMID:
28196059
20.

β2-Adrenergic Receptor Antagonism Attenuates CNV Through Inhibition of VEGF and IL-6 Expression.

Lavine JA, Farnoodian M, Wang S, Darjatmoko SR, Wright LS, Gamm DM, Ip MS, Sorenson CM, Sheibani N.

Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):299-308. doi: 10.1167/iovs.16-20204.

21.

VEGF regulates local inhibitory complement proteins in the eye and kidney.

Keir LS, Firth R, Aponik L, Feitelberg D, Sakimoto S, Aguilar E, Welsh GI, Richards A, Usui Y, Satchell SC, Kuzmuk V, Coward RJ, Goult J, Bull KR, Sharma R, Bharti K, Westenskow PD, Michael IP, Saleem MA, Friedlander M.

J Clin Invest. 2017 Jan 3;127(1):199-214. doi: 10.1172/JCI86418. Epub 2016 Dec 5.

22.

SCORE2 Report 2: Study Design and Baseline Characteristics.

Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, Figueroa M, Dugel PU; SCORE2 Investigator Group.

Ophthalmology. 2017 Feb;124(2):245-256. doi: 10.1016/j.ophtha.2016.09.038. Epub 2016 Nov 15.

23.

SCORE2 Report 1: Techniques to Optimize Recruitment in Phase III Clinical Trials of Patients With Central Retinal Vein Occlusion.

Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, Figueroa M; SCORE2 Investigator Group.

Am J Ophthalmol. 2016 Oct;170:25-31. doi: 10.1016/j.ajo.2016.07.011. Epub 2016 Jul 19.

24.

Aberrant Accumulation of the Diabetes Autoantigen GAD65 in Golgi Membranes in Conditions of ER Stress and Autoimmunity.

Phelps EA, Cianciaruso C, Michael IP, Pasquier M, Kanaani J, Nano R, Lavallard V, Billestrup N, Hubbell JA, Baekkeskov S.

Diabetes. 2016 Sep;65(9):2686-99. doi: 10.2337/db16-0180. Epub 2016 Jun 9.

25.

Functional malignant cell heterogeneity in pancreatic neuroendocrine tumors revealed by targeting of PDGF-DD.

Cortez E, Gladh H, Braun S, Bocci M, Cordero E, Björkström NK, Miyazaki H, Michael IP, Eriksson U, Folestad E, Pietras K.

Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):E864-73. doi: 10.1073/pnas.1509384113. Epub 2016 Feb 1.

26.

Reply.

Eadie JA, Ip MS.

Retina. 2016 Feb;36(2):e10-2. doi: 10.1097/IAE.0000000000000918. No abstract available.

PMID:
26696314
27.

KLK5 Inactivation Reverses Cutaneous Hallmarks of Netherton Syndrome.

Furio L, Pampalakis G, Michael IP, Nagy A, Sotiropoulou G, Hovnanian A.

PLoS Genet. 2015 Sep 21;11(9):e1005389. doi: 10.1371/journal.pgen.1005389. eCollection 2015 Sep.

28.

Reply: To PMID 24999721.

Eadie JA, Ip MS.

Retina. 2015 Aug;35(8):e54-5. doi: 10.1097/IAE.0000000000000682. No abstract available.

PMID:
26166802
29.

Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein Occlusion: SCORE Study Report 15.

Aref AA, Scott IU, Oden NL, Ip MS, Blodi BA, VanVeldhuisen PC; SCORE Study Investigator Group.

JAMA Ophthalmol. 2015 Sep;133(9):1022-9. doi: 10.1001/jamaophthalmol.2015.1823.

PMID:
26086920
30.

Corrigendum: Divergent reprogramming routes lead to alternative stem-cell states.

Tonge PD, Corso AJ, Monetti C, Hussein SM, Puri MC, Michael IP, Li M, Lee DS, Mar JC, Cloonan N, Wood DL, Gauthier ME, Korn O, Clancy JL, Preiss T, Grimmond SM, Shin JY, Seo JS, Wells CA, Rogers IM, Nagy A.

Nature. 2015 Jul 30;523(7562):626. doi: 10.1038/nature14607. Epub 2015 Jun 17. No abstract available.

PMID:
26083751
31.

Modeling correction of severe urea cycle defects in the growing murine liver using a hybrid recombinant adeno-associated virus/piggyBac transposase gene delivery system.

Cunningham SC, Siew SM, Hallwirth CV, Bolitho C, Sasaki N, Garg G, Michael IP, Hetherington NA, Carpenter K, de Alencastro G, Nagy A, Alexander IE.

Hepatology. 2015 Aug;62(2):417-28. doi: 10.1002/hep.27842. Epub 2015 May 23.

PMID:
26011400
32.

Effects of intravitreal ranibizumab on retinal hard exudate in diabetic macular edema: findings from the RIDE and RISE phase III clinical trials.

Domalpally A, Ip MS, Ehrlich JS.

Ophthalmology. 2015 Apr;122(4):779-86. doi: 10.1016/j.ophtha.2014.10.028. Epub 2015 Jan 17.

33.

Divergent reprogramming routes lead to alternative stem-cell states.

Tonge PD, Corso AJ, Monetti C, Hussein SM, Puri MC, Michael IP, Li M, Lee DS, Mar JC, Cloonan N, Wood DL, Gauthier ME, Korn O, Clancy JL, Preiss T, Grimmond SM, Shin JY, Seo JS, Wells CA, Rogers IM, Nagy A.

Nature. 2014 Dec 11;516(7530):192-7. doi: 10.1038/nature14047. Erratum in: Nature. 2015 Jul 30;523(7562):626.

PMID:
25503232
34.

Long-term effects of therapy with ranibizumab on diabetic retinopathy severity and baseline risk factors for worsening retinopathy.

Ip MS, Domalpally A, Sun JK, Ehrlich JS.

Ophthalmology. 2015 Feb;122(2):367-74. doi: 10.1016/j.ophtha.2014.08.048. Epub 2014 Nov 18.

35.

Localized retinal manifestations of paraneoplastic autoimmune retinopathy.

Eadie JA, Ip MS, Ver Hoeve JN.

Retin Cases Brief Rep. 2014 Fall;8(4):318-21. doi: 10.1097/ICB.0000000000000054.

PMID:
25372537
36.

Response to aflibercept in patients with persistent exudation despite prior treatment with bevacizumab or ranibizumab for age-related macular degeneration.

Eadie JA, Gottlieb JL, Ip MS, Blodi BA, Danis RP, Chandra SR, Nork TM, Altaweel MM, Stern-Hogan BS.

Ophthalmic Surg Lasers Imaging Retina. 2014 Sep-Oct;45(5):394-7.

PMID:
25230402
37.
38.

Local acting Sticky-trap inhibits vascular endothelial growth factor dependent pathological angiogenesis in the eye.

Michael IP, Westenskow PD, Hacibekiroglu S, Greenwald AC, Ballios BG, Kurihara T, Li Z, Warren CM, Zhang P, Aguilar E, Donaldson L, Marchetti V, Baba T, Hussein SM, Sung HK, Iruela-Arispe ML, Rini JM, van der Kooy D, Friedlander M, Nagy A.

EMBO Mol Med. 2014 May;6(5):604-23. doi: 10.1002/emmm.201303708.

39.

Ras pathway inhibition prevents neovascularization by repressing endothelial cell sprouting.

Westenskow PD, Kurihara T, Aguilar E, Scheppke EL, Moreno SK, Wittgrove C, Marchetti V, Michael IP, Anand S, Nagy A, Cheresh D, Friedlander M.

J Clin Invest. 2013 Nov;123(11):4900-8.

40.

MBNL proteins repress ES-cell-specific alternative splicing and reprogramming.

Han H, Irimia M, Ross PJ, Sung HK, Alipanahi B, David L, Golipour A, Gabut M, Michael IP, Nachman EN, Wang E, Trcka D, Thompson T, O'Hanlon D, Slobodeniuc V, Barbosa-Morais NL, Burge CB, Moffat J, Frey BJ, Nagy A, Ellis J, Wrana JL, Blencowe BJ.

Nature. 2013 Jun 13;498(7453):241-5. doi: 10.1038/nature12270. Epub 2013 Jun 5.

41.

Simple piggyBac transposon-based mammalian cell expression system for inducible protein production.

Li Z, Michael IP, Zhou D, Nagy A, Rini JM.

Proc Natl Acad Sci U S A. 2013 Mar 26;110(13):5004-9. doi: 10.1073/pnas.1218620110. Epub 2013 Mar 8.

42.

Adipose vascular endothelial growth factor regulates metabolic homeostasis through angiogenesis.

Sung HK, Doh KO, Son JE, Park JG, Bae Y, Choi S, Nelson SM, Cowling R, Nagy K, Michael IP, Koh GY, Adamson SL, Pawson T, Nagy A.

Cell Metab. 2013 Jan 8;17(1):61-72. doi: 10.1016/j.cmet.2012.12.010.

43.

Attenuation of choroidal neovascularization by β(2)-adrenoreceptor antagonism.

Lavine JA, Sang Y, Wang S, Ip MS, Sheibani N.

JAMA Ophthalmol. 2013 Mar;131(3):376-82. doi: 10.1001/jamaophthalmol.2013.1476.

44.

Highly efficient site-specific transgenesis in cancer cell lines.

Michael IP, Monetti C, Chiu AC, Zhang P, Baba T, Nishino K, Agha-Mohammadi S, Woltjen K, Sung HK, Nagy A.

Mol Cancer. 2012 Dec 11;11:89. doi: 10.1186/1476-4598-11-89.

45.

Baseline characteristics and response to treatment of participants with hemiretinal compared with branch retinal or central retinal vein occlusion in the standard care vs corticosteroid for retinal vein occlusion (SCORE) study: SCORE study report 14.

Scott IU, Vanveldhuisen PC, Oden NL, Ip MS, Domalpally A, Doft BH, Elman MJ, Blodi BA; SCORE Study Investigator Group.

Arch Ophthalmol. 2012 Dec;130(12):1517-24. doi: 10.1001/archophthalmol.2012.2728.

PMID:
23229691
46.

Interventions for toxoplasma retinochoroiditis: a report by the American Academy of Ophthalmology.

Kim SJ, Scott IU, Brown GC, Brown MM, Ho AC, Ip MS, Recchia FM.

Ophthalmology. 2013 Feb;120(2):371-8. doi: 10.1016/j.ophtha.2012.07.061. Epub 2012 Oct 11. Review.

PMID:
23062648
47.

Score Study Report 12: Development of venous collaterals in the Score Study.

Weinberg DV, Wahle AE, Ip MS, Scott IU, VanVeldhuisen PC, Blodi BA; SCORE Study Investigator Group.

Retina. 2013 Feb;33(2):287-95. doi: 10.1097/IAE.0b013e318263d106.

48.

Long-term effects of ranibizumab on diabetic retinopathy severity and progression.

Ip MS, Domalpally A, Hopkins JJ, Wong P, Ehrlich JS.

Arch Ophthalmol. 2012 Sep;130(9):1145-52. doi: 10.1001/archophthalmol.2012.1043.

PMID:
22965590
49.

Anti-vascular endothelial growth factor pharmacotherapy for diabetic macular edema: a report by the American Academy of Ophthalmology.

Ho AC, Scott IU, Kim SJ, Brown GC, Brown MM, Ip MS, Recchia FM.

Ophthalmology. 2012 Oct;119(10):2179-88. doi: 10.1016/j.ophtha.2012.07.058. Epub 2012 Aug 20. Review.

PMID:
22917890
50.

Diabetic macular edema: therapeutic options.

Kulkarni AD, Ip MS.

Diabetes Ther. 2012 Nov;3(1):1-14. doi: 10.1007/s13300-012-0002-y. Epub 2012 Mar 6.

Supplemental Content

Loading ...
Support Center